Wolverine Trading’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-12,500
Closed -$95K 4514
2019
Q1
$95K Buy
12,500
+1,500
+14% +$11.7K ﹤0.01% 4162
2018
Q4
$86K Buy
+11,000
New +$109K ﹤0.01% 4030
2018
Q3
Sell
-36,900
Closed -$260K 5044
2018
Q2
$260K Hold
36,900
﹤0.01% 3984
2018
Q1
$260K Buy
36,900
+14,000
+61% +$106K ﹤0.01% 3984
2017
Q4
$149K Buy
22,900
+3,100
+16% +$19.7K ﹤0.01% 4304
2017
Q3
$123K Buy
19,800
+8,900
+82% +$45.4K ﹤0.01% 4002
2017
Q2
$48K Buy
10,900
+100
+0.9% +$438 ﹤0.01% 4067
2017
Q1
$59K Sell
10,800
-7,800
-42% -$43.6K ﹤0.01% 3968
2016
Q4
$101K Buy
+18,600
New +$102K ﹤0.01% 4054

Other funds holding CTSO

Wolverine Trading's CTSO Position: Q2 2020 in Review

Wolverine Trading sold out of Cytosorbents Corp (CTSO) in Q2 2020, closing a stake of 25,735 shares — an estimated $236K sold.

Wolverine Trading first reported a position in CTSO in Q2 2016 and held it in 12 quarters. The position peaked at $222K in Q3 2018. 91 funds tracked by Wall St. Rank hold CTSO as of Q2 2020.

  • Wolverine Trading reported no remaining Cytosorbents Corp position as of Q2 2020 after selling out during the quarter.
  • Wolverine Trading sold 25,735 Cytosorbents Corp shares in Q2 2020, an estimated $236K.
  • Wolverine Trading first reported a position in Cytosorbents Corp in Q2 2016 and held it in 12 quarters.
  • Wolverine Trading's Cytosorbents Corp position peaked at $222K in Q3 2018.
  • 91 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2020.

Based on Wolverine Trading's 13F filing for Q2 2020, filed 13 Aug 2020.